Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BF8Y
|
|||
| Former ID |
DIB008239
|
|||
| Drug Name |
Pelareorep
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 3 | [1] | |
| Fallopian tube cancer [ICD-11: 2C74; ICD-10: C57.0] | Phase 2 | [2] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [2] | ||
| Peritoneal cavity cancer [ICD-11: 2C51.Z] | Phase 2 | [2] | ||
| Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1], [2] | ||
| Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [1] | ||
| Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1 | [1] | ||
| Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1 | [2] | ||
| Multiple myeloma [ICD-11: 2A83; ICD-10: C90.0] | Phase 1 | [1] | ||
| Company |
Oncolytics biotech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.